Search

The purpose of this study was to determine the relative contributions of isokinetic forearm flexion (FLX) and extension (EXT) peak torque (PT) at 180°·s, height (HT), percent body fat (%BF), and fat-free mass (FFM) to the prediction of estimated propulsive force (EPF) and which of these variables should be a focus of training in young male swimmers. Thirty young male swimmers (mean age ± SD = 12.4 ± 2.7 years) volunteered for this study. The subjects were members of local swimming clubs who competed in the front crawl. The swimmers were measured for FLX and EXT PT at 180°·s, HT, body mass (BM), arm muscle area (AMA), arm circumference, triceps skinfold, %BF, and FFM. Arm muscle area was used to calculate EPF. Zero-order correlations and stepwise multiple regression analyses were used to examine the relationships among variables and the relative contributions of FLX, EXT, HT, %BF, and FFM to the prediction of EPF. Forearm flexion PT at 180°·s, EXT, BM, HT, FFM, AMA, and EPF were significantly intercorrelated (r = 0.83-1.00). In addition, 4 variables contributed significantly to the prediction of EPF (standardized regression coefficients = FFM [1.00], FLX [0.92], EXT [-0.62], and HT [-0.35]). Percent body fat did not contribute to any of the stepwise models. These findings suggested that age-related increases in HT and FFM, as well as training for increases in FLX and EXT strength may improve propulsive force and swimming performance in young male swimmers.

The purposes of this study were to: (a) examine the age-related patterns of differences in height (HT), body mass (BM), percent body fat (% fat), body mass index (BMI), and skinfolds (SF) in 11- to 18-year-old wrestlers; (b) determine the coherence of direct (% fat) and indirect (BMI and SFs) indicators of adiposity in the wrestlers; and (c) compare the age-related patterns and mean values for HT, BM, BMI, subscapular, and triceps SF for the wrestlers to those of national samples of boys from the National Health and Nutrition Examination Survey (NHANES) database. One hundred thirty wrestlers were divided into 8 independent yearly age groups (AG): AG11-AG18 years. Height, BM, BMI, subscapular SF, triceps SF, medial calf SF, thigh SF, sum of SFs, and % fat were assessed. There were no differences between the wrestlers and NHANES samples for age-related patterns of BMI (0.61 and 0.63 kg·m·y), subscapular SF (0.47 and 0.37 mm·y), or triceps SF (-0.31 and -0.39 mm·y). Furthermore, the wrestlers displayed no differences in % fat between age groups. The results indicated that: (a) dissociations existed between the direct and indirect indicators of adiposity; (b) the wrestlers were similar in height but had smaller upper-body SFs when compared with NHANES samples; and (c) participation in wrestling (1-8 years) had no adverse effects on the normal age-related growth patterns for HT, but favorable effects on measures of adiposity.

Twenty-one men (mean ± SD; age = 23.5 ± 2.6 years, BMI = 26.0 ± 2.4 kg-1·m-2) completed this randomized, double-blinded, placebo-controlled, crossover study to examine acute responses to a thermogenic nutritional supplement. Each testing session included: (a) 30 minutes resting, followed by placebo or thermogenic nutritional supplementation, (b) 50 minutes postsupplementation resting, (c) 60 minutes walking, and (d) 50 minutes postexercise recovery. Gas exchange variables and heart rate (HR) were recorded during each phase. Blood pressure was recorded during all phases except exercise. Ratings of perceived exertion (RPE) were recorded only during exercise. There were no significant differences for any of the measures between the supplement and placebo during the initial resting or postsupplementation phases. During exercise, energy expenditure (EE) (placebo = 18.98-19.06 kJ·min-1 and supplement = 19.44-19.82 kJ·min-1) and VO2 (placebo = 11.27-11.35 ml·kg-1·min-1; supplement = 11.64-11.82 ml·kg-1·min-1) were greater for the supplement than placebo. There were no differences in respiratory exchange ratio (RER), HR, or RPE between the supplement and placebo during exercise. Postexercise, only VO2 (placebo = 3.53-3.63 ml·kg-1·min-1; supplement = 3.71-3.84 ml·kg-1·min-1) was greater for the supplement than placebo, but there were no differences in EE, RER, HR, or blood pressure. These findings suggested that the specific blend of ingredients in the thermogenic nutritional supplement, when combined with exercise, increased the metabolic rate with minimal changes in cardiovascular function and no effect on RPE.

The purpose of this study was to examine the effects of 28 days of polyethylene glycosylated creatine (PEG-creatine) supplementation (1.25 and 2.50 g·d) on anaerobic performance measures (vertical and broad jumps, 40-yard dash, 20-yard shuttle run, and 3-cone drill), upper- and lower-body muscular strength and endurance (bench press and leg extension), and body composition. This study used a randomized, double-blind, placebo-controlled parallel design. Seventy-seven adult men (mean age ± SD, 22.1 ± 2.5 years; body mass, 81.7 ± 10.8 kg) volunteered to participate and were randomly assigned to a placebo (n = 23), 1.25 g·d of PEG-creatine (n = 27), or 2.50 g·d of PEG-creatine (n = 27) group. The subjects performed anaerobic performance measures, muscular strength (one-repetition maximum [1RM]), and endurance (80% 1RM) tests for bench press and leg extension, and underwater weighing for the determination of body composition at day 0 (baseline), day 14, and day 28. The results indicated that there were improvements (p < 0.0167) in vertical jump, 20-yard shuttle run, 3-cone drill, muscular endurance for bench press, and body mass for at least one of the PEG-creatine groups without changes for the placebo group. Thus, the present results demonstrated that PEG-creatine supplementation at 1.25 or 2.50 g·d had an ergogenic effect on lower-body vertical power, agility, change-of-direction ability, upper-body muscular endurance, and body mass.

The purpose of this study was to examine the effects of 7 days of supplementation with 20 g·d⁻¹ of creatine monohydrate (CM) on mean power (MP) and peak power (PP) from the Wingate anaerobic test (WAnT), body weight (BW), 1-repetition maximum (1RM) bilateral leg extension (LE) strength, and 1RM bench press (BP) strength. This study used a randomized, double-blind, placebo-controlled design. Twenty-two men (mean ± SD: age = 22.1 ± 2.0 years; height = 178.0 ± 5.8 cm; body weight [BW] = 77.6 ± 7.6 kg) were randomly assigned to either a supplement (SUPP; n = 10) or placebo (PLAC; n = 12) group. The SUPP group ingested 20 g·d⁻¹ of CM powder for 7 days, whereas the PLAC ingested 20 g·d⁻¹ of maltodextrin powder. Measurements for the PLAC and SUPP groups included BW, PP, and MP from two 30-second WAnTs (separated by 7 minutes), and 1RM strength for LE and BP. Testing was conducted before (PRE) and after (POST) 7 days of ingesting either the supplement or placebo. The results of this study indicated that there was a significant (p ≤ 0.05) increase from PRE to POST testing in MP for the SUPP group (5.4%) but not for the PLAC group (-0.3%). There were no between-group differences, however, for 1RM LE and 1RM BP strength. Furthermore, there were no changes in PP or BW for either group. The findings of this study indicated that loading with 20 g·d⁻¹ of CM for 7 days increased MP (5.4% increase) from the WAnT, but it had no effect on strength (1RM LE and 1RM BP), PP, or BW.

The purpose of the present study was to compare the age-related patterns of anthropometric dimensions of female high school gymnasts to those of a national representative sample of teenage girls. One hundred and one female high school gymnasts (X ± SD age = 15.8 ± 1.1 year; height [HT] = 162.2 ± 5.7 cm; body weight [BW] = 54.1 ± 6.5 kg) volunteered as subjects in the present study. The sample was divided into 4 independent age groups: age group 14 (AG14) = 14.00 to 14.99 years (n = 26); AG15 = 15.00 to 15.99 years (n = 27); AG16 = 16.00 to 16.99 years (n = 29); and AG17 = 17.00 to 17.99 years (n = 19). Nine variables including BW; HT; body mass index (BMI); subscapular and triceps skinfolds; and waist, mid-arm, maximal calf, and mid-thigh circumferences were assessed on each subject. Independent t-tests indicated that for all age groups, the female high school gymnasts exhibited lower BW, BMI, circumferences (waist, mid-arm, maximal calf, and mid-thigh) and skinfolds (subscapular and triceps) than the national sample, except AG 17 for BW and maximal calf and mid-thigh circumferences. There were no significant differences in HT between samples for any of the age groups. Furthermore, there were no differences between the high school gymnasts and the national sample for the slope coefficients for the anthropometric dimensions vs. age relationships. These findings indicated that in females, participation in high school gymnastics does not adversely affect yearly changes in anthropometric dimensions.

The purpose of this study was to compare the body composition, body build, and anthropometric characteristics of boy and girl sprint swimmers. Two groups (boys, n = 38 and girls, n = 31) of sprint swimmers (mean age ± SD = 11.03 ± 2.29 and 10.45 ± 2.29 years, respectively) volunteered for this study. The subjects were members of local swimming clubs who competed in sprint swimming events (≤ 200 m). Gender comparisons were made for age, body weight (BW), height (HT), fat-free weight (FFW), percent body fat (%fat), endomorphic rating, mesomorphic rating, ectomorphic rating, sum of 12 diameters, sum of 11 circumferences, biacromial diameter/biiliac diameter, and FFW/HT. The results of the independent t-tests indicated that the only mean differences between the boy and girl sprint swimmers were for % fat (boys = 9.40 ± 5.35% fat; girls = 12.73 ± 6.19% fat) and endomorphic rating (boys = 2.87 ± 0.96; girls = 4.29 ± 1.22). For the current age group of sprint swimmers the only gender differences were for measures associated with body fatness, and there were no differences for body build measures associated with musculoskeletal size, muscularity, skeletal size, total body mass, or body breadth dimensions. These findings suggest that the swimming performance for girls may be improved through training programs designed to reduce body fatness.

The purpose of the present investigation was to examine the effects of 28 days of polyethylene glycosylated creatine (PEG-creatine) supplementation on 1-repetition maximum bench press (1RMBP) and leg extension (1RMLE), mean power (MP), and peak power (PP) from the Wingate Anaerobic test and body weight (BW). This study used a randomized, double-blind, placebo-controlled, parallel design. Twenty-two untrained men (mean age ± SD = 22.1 ± 2.1 years) were randomly assigned to either a Creatine (n = 10) or Placebo (n = 12) group. The Creatine group ingested PEG-creatine (5 g·d), whereas the Placebo group ingested maltodextrin powder (5 g·d). All subjects performed bench press and bilateral leg extension exercises to determine their 1RM values, and 2 consecutive Wingate Anaerobic Tests (separated by 7 minutes) on a cycle ergometer to determine MP and PP before supplementation (day 0) and after 7 (day 7) and 28 (day 28) days of supplementation. The results indicated that there was a significant (p < 0.05) increase in 1RMBP between days 0 and 28 for the Creatine group but not for the Placebo group. There were no significant changes, however, in 1RMLE, MP, PP, or BW for the Creatine or Placebo group. These findings indicated that 28 days of PEG-creatine supplementation without resistance training increased upper body strength but not lower body strength or muscular power. These findings supported the use of the PEG-creatine supplement for increasing 1RMBP strength in untrained individuals.

The purposes of the present study were to determine the patterns of age-related changes in 1) height (HT), body weight (BW), fat-free weight (FFW), and absolute isokinetic peak torque (PT); and 2) isokinetic PT covaried separately for HT, BW, FFW, and HT and BW combined in young wrestlers. One hundred twenty-five male wrestlers (mean age +/- SD = 14.3 +/- 2.4 yr; range = 11.1-18.2 yr) volunteered to perform concentric, isokinetic leg extension and flexion at 180 degrees xs-1 on a Cybex II dynamometer to measure PT as well as underwater weighing to determine FFW. The polynomial regression analyses indicated there were significant quadratic increases across age for HT (R = 0.62), BW (R = 0.56), and FFW (R = 0.47). For leg extension, there were significant increases across age for absolute PT (quadratic, R = 0.66), PT covaried for HT (linear, r = 0.10), PT covaried for BW (linear, r = 0.12), PT covaried for FFW (quadratic, R = 0.32), and PT covaried for HT and BW combined (quadratic, R = 0.11). For leg flexion, there were significant increases across age for absolute PT (linear, r = 0.59), PT covaried for HT (linear, r = 0.07), PT covaried for BW (linear, r = 0.08), PT covaried for FFW (quadratic, R = 0.23), and PT covaried for BW and HT combined (linear, r = 0.03). The results of this study indicated that age-related increases in leg-extension and flexion PT for the current sample of young wrestlers could not be accounted for by changes in HT, BW, FFW, or HT and BW combined. These findings suggested that neural maturation may contribute to increases in leg strength across age in young wrestlers.

The purpose of the present study was to examine the acute effects of a caffeine-containing supplement (SUPP) on 1 repetition maximum (1RM) bench press and leg extension strength, as well as time to exhaustion (TTE), during cycle ergometry at a power output that corresponded to 80% of VO2peak. The study used a double-blinded, placebo-controlled, crossover design. Twenty-one untrained men (mean +/- SD age = 23.0 +/- 2.6 yr) were randomly assigned to take either the SUPP or placebo (PLAC) first. The SUPP contained 400 mg of caffeine, 66.7 mg of capsicum extract, 10 mg of bioperine, and 40 mg of niacin, and the PLAC was microcrystalline cellulose. Sixty minutes after taking either the SUPP or PLAC, the subjects were tested for 1RM bench press and leg extension strength, as well as TTE. After 1 week of rest, the subjects ingested the opposite substance (SUPP or PLAC) and were retested for 1RM bench press and leg extension strength, as well as TTE. The results indicated that the SUPP had no effect on 1RM bench press strength, 1RM leg extension strength, or TTE at 80% VO2peak. These findings did not support the use of the caffeine-containing SUPP in the present study as an ergogenic aid in untrained individuals.

The purposes of this study were to 1) compare the patterns of responses for plasma ammonia concentration ([NH3]) during moderate- vs. heavy-intensity cycle ergometry, and 2) examine the relationship between the V O2 slow component (V O 2SC) and plasma [NH3]. Thirteen healthy, untrained men (mean +/- SEM age = 24.8 +/- 0.6 years) performed a total of eight constant power output exercises (7 minutes in duration) at two different intensities (moderate, 60% gas exchange threshold [GET] = 60% of the gas exchange threshold; and heavy, Delta 50% = 50% of the difference between GET and V O2 max). Blood was collected from an antecubital vein before the exercise, during the last 3 minutes of the 6-minute warm-up, and during each minute of the 7-minute constant power output workbout. The time course of changes in plasma [NH3] and V O2 during the two constant power output exercise intensities were assessed separately using 2 (intensity) x 7 (time) repeated-measures analyses of variance. For 60% GET, there were no significant differences in the mean normalized plasma [NH3] during the 7-minute workbout. For Delta 50%, there was a significant increase in the mean normalized plasma [NH3] during the 7-minute workbout. These findings suggest a potential relationship between exercise-induced hyperammonemia and the V O 2SC during heavy-intensity exercise.

This investigation examined the effects of a protease supplement on selected markers of muscle damage and delayed-onset muscle soreness (DOMS). The study used a double-blinded, placebo-controlled, crossover design. Twenty men (mean +/- SD age = 21.0 +/- 3.1 years) were randomly assigned to either a supplement group (SUPP) or a placebo group (PLAC). All subjects were tested for unilateral isometric forearm flexion strength, hanging joint angle, relaxed arm circumference, subjective pain rating, and plasma creatine kinase activity and myoglobin concentration. The testing occurred before (TIME1), immediately after (TIME2), and 24 (TIME3), 48 (TIME4), and 72 (TIME5) hours after a bout of eccentric exercise. During these tests, the subjects in the SUPP group ingested a protease supplement. The subjects in the PLAC group took microcrystalline cellulose. After testing at TIME5 and 2 weeks of rest, the subjects were crossed over into the opposite group and performed the same tests as during visits 1-5, but with the opposite limb. Overall, isometric forearm flexion strength was greater (7.6%) for the SUPP group than for the PLAC group, despite nearly identical (difference = 0.14 N.m, p = 0.940) mean strength values before (TIME1) the eccentric exercise protocol. There were no between-group differences for hanging joint angle, relaxed arm circumference, subjective pain ratings, and plasma creatine kinase activity and myoglobin concentration from TIME1 to TIME5. These findings provided initial evidence that the protease supplement may be useful for reducing strength loss immediately after eccentric exercise and for aiding in short-term strength recovery. The protease supplement had no effect, however, on the perception of pain associated with DOMS or the blood markers of muscle damage.

The purpose of this study was to examine the effects of daily administration of a supplement that contained caffeine in conjunction with 8 weeks of aerobic training on VO(2)peak, time to running exhaustion at 90% VO(2)peak, body weight, and body composition. Thirty-six college students (14 men and 22 women; mean +/- SD, age 22.4 +/- 2.9 years) volunteered for this investigation and were randomized into either a placebo (n = 18) or supplement group (n = 18). The subjects ingested 1 dose (3 pills = 201 mg of caffeine) of the placebo or supplement per day during the study period. In addition, the subjects performed treadmill running for 45 minutes at 75% of the heart rate at VO(2)peak, three times per week for 8 weeks. All subjects were tested pretraining and posttraining for VO(2)peak, time to running exhaustion (TRE) at 90% VO(2)peak, body weight (BW), percentage body fat (%FAT), fat weight (FW), and fat-free weight (FFW). The results indicated that there were equivalent training-induced increases (p < 0.05) in VO(2)peak and TRE for the supplement and placebo groups, but no changes (p > 0.05) in BW, %FAT, FW, or FFW for either group. These findings indicated that chronic use of the caffeine-containing supplement in the present study, in conjunction with aerobic training, provided no ergogenic effects as measured by VO(2)peak and TRE, and the supplement was of no benefit for altering body weight or body composition.

The purpose of this study was to examine the acute effects of a caffeine-containing supplement on upper- and lower-body strength and muscular endurance as well as anaerobic capabilities. Thirty-seven resistance-trained men (mean +/- SD, age: 21 +/- 2 years) volunteered to participate in this study. On the first laboratory visit, the subjects performed 2 Wingate Anaerobic Tests (WAnTs) to determine peak power (PP) and mean power (MP), as well as tests for 1 repetition maximum (1RM), dynamic constant external resistance strength, and muscular endurance (TOTV; total volume of weight lifted during an endurance test with 80% of the 1RM) on the bilateral leg extension (LE) and free-weight bench press (BP) exercises. Following a minimum of 48 hours of rest, the subjects returned to the laboratory for the second testing session and were randomly assigned to 1 of 2 groups: a supplement group (SUPP; n = 17), which ingested a caffeine-containing supplement, or a placebo group (PLAC; n = 20), which ingested a cellulose placebo. One hour after ingesting either the caffeine-containing supplement or the placebo, the subjects performed 2 WAnTs and were tested for 1RM strength and muscular endurance on the LE and BP exercises. The results indicated that there was a significant (p < 0.05) increase in BP 1RM for the SUPP group, but not for the PLAC group. The caffeine-containing supplement had no effect, however, on LE 1RM, LE TOTV, BP TOTV, PP, and MP. Thus, the caffeine-containing supplement may be an effective supplement for increasing upper-body strength and, therefore, could be useful for competitive and recreational athletes who perform resistance training.

The purpose of this study was to determine the effects of resistance training in combination with a leucine and whey protein supplement or a carbohydrate placebo on strength and muscle cross-sectional area (CSA). Thirty-three men (mean age +/- SD = 22.4 +/- 2.4 years) were assigned to 1 of 3 groups: (1) supplementation group (SUPP), (2) placebo group (PL), or (3) control group (CON). The SUPP and PL performed unilateral training of the leg extensor muscles with the nondominant limb for 8 weeks. The strength of each limb, muscle CSA of the quadriceps femoris (QF), and body composition were assessed pretraining and posttraining. The results indicated significant increases in strength for both limbs in the SUPP but only the trained limb in the PL. The increase in strength for the trained limb of the SUPP was greater than that for the trained limb of the PL. There was no significant increase in strength for either limb in the CON. There were significant increases in the CSA of all muscles of the QF of the trained limb for the SUPP and PL, and of the vastus lateralis of the untrained limb for the SUPP. The increases in QF CSA did not differ between the SUPP and PL. No significant CSA changes were found for either limb in the CON. There were no significant changes in body composition for the SUPP, PL, or CON. The current findings suggest that leucine and whey protein supplementation may provide an ergogenic effect which enhances the acquisition of strength beyond that achieved with resistance training and a carbohydrate placebo.

The purpose of this investigation was to determine the accuracy of near-infrared interactance (NIR) instruments and population-specific NIR equations for estimating percent body fat (% fat) in young wrestlers. Forty-four white male youth wrestlers (mean age +/- SD = 11.0 +/- 2.1 years) volunteered for this study. Thirteen NIR % fat estimates were cross-validated against the criterion % fat from underwater weighing. The results of this study indicated that the total error (TE) values associated with the NIR instrument generated % fat estimates as well as % fat estimates from population-specific NIR equations developed for high school wrestlers or adult men were too large (TE = 5.7-27.3% fat) to be used with young wrestlers. Based on the present findings, it is recommended that new NIR equations be developed and validated specifically for use in young male athletes.